Clinical Trials Directory

Trials / Completed

CompletedNCT00180271

MADIT-CRT: Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy

Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,820 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The MADIT-CRT trial is designed to determine if combined implantable cardiac defibrillator (ICD)-cardiac resynchronization therapy (CRT-D) will reduce the risk of mortality and heart failure (HF) events by approximately 25%, in subjects who are in New York Heart Association (NYHA) functional Class II with non-ischemic or ischemic cardiomyopathy and subjects who are in NYHA functional Class I with ischemic cardiomyopathy, left ventricular dysfunction (ejection fraction \[EF\] \< or = 0.30), and prolonged intraventricular conduction (QRS duration \> or = 130 ms).

Detailed description

In this study, subjects will be randomized to CRT-D or ICD-only. Randomization will be stratified by clinical center and ischemic status. Approximately 60% of the subjects will be randomly assigned to receive a CRT-D with biventricular pacing, and 40% will receive an ICD only. Optimal pharmacological therapy for heart failure will be required in both treatment arms. Length of follow-up for each subject will depend on the date of entry into the study, since all subjects will be followed to a common study termination date.

Conditions

Interventions

TypeNameDescription
DEVICECardiac resynchronization therapy with defibrillationBoston Scientific Corporation Market Released Cardiac Resynchronization therapy with defibrillation
DEVICEImplantable Cardioverter Defibrillator (ICD)Boston Scientific Corporation Market Released Implantable Cardioverter Defibrillator

Timeline

Start date
2004-12-01
Primary completion
2009-06-01
Completion
2010-09-01
First posted
2005-09-16
Last updated
2018-12-19
Results posted
2011-06-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00180271. Inclusion in this directory is not an endorsement.